Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting

Updated data from EDGE-Gastric evaluating domvanalimab plus zimberelimab and chemotherapy in upper gastrointestinal cancers will be presented in a special ASCO plenary series rapid abstract update...

Related Keywords

United States ,American ,Terry Rosen ,Gilead Sciences ,Arcus Biosciences Inc ,American Society Of Clinical Oncology ,Arcus Biosciences ,Clinical Oncology ,Annual Meeting ,Rapid Abstract Updates ,Lung Cancer ,Non Small Cell ,Randomized Study ,Previously Treated Metastatic Colorectal Cancer ,Oral Abstract Session ,Arcus Bioscience ,